Results of a recent preclinical study provide proof of concept that an mRNA HIV vaccine is safe, immunogenic, and induces CD4–T-cell responses.
Kmeone Kingdom, MPH, PharmD candidate
Advertisement
Articles by Kmeone Kingdom, MPH, PharmD candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Updated Diabetes Consensus Shifts Focus from Glucose Control to Whole-Person Care
2
No Added Adverse Event Risk in Pfizer-BioNTech COVID-19 Vaccine
3
Q&A: Overlapping PBM, 340B Reform Create Uncertainty for Pharmacies
4
What the CLARITY Study Means for Counseling on Long-Acting HIV PrEP
5